Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Yunzhou Pu, Qing Ji
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma
Fen Zhao, Hui Tian, Yungang Wang, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 6, pp. 1835-1851
Open Access | Times Cited: 14
Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy
Rui Han, Xiwu Rao, Huiling Zhou, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4803-4834
Open Access | Times Cited: 5
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
Víctor Albarrán, Patrícia Guerrero, Coral García de Quevedo, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 5
Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 4
New Strategies for Macrophage Re-Education in Cancer: An Update
Nadia Lampiasi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3414-3414
Open Access | Times Cited: 4
The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
Marlene Kohlhepp, Hanyang Liu, Frank Tacke, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape
Meenakshi Sudhakaran, Andrea I. Doseff
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5086-5086
Open Access | Times Cited: 13
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 13
Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
Rong Xu, Youngjoo Lee, Chang-Hyeon Kim, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Biochemical implications of robotic surgery: a new frontier in the operating room
Leila Mokhtari, Fatemeh Hosseinzadeh, Alireza Nourazarian
Journal of Robotic Surgery (2024) Vol. 18, Iss. 1
Closed Access | Times Cited: 3
Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?
Rossella Fasano, Simona Serratì, Tania Rafaschieri, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 396-396
Open Access | Times Cited: 3
Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy
Bao-Toan Nguyen Dang, Ramesh Duwa, Sooyeun Lee, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 587-608
Closed Access | Times Cited: 3
Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire
Shaivy Malik, Niti Sureka, Sana Ahuja, et al.
Cell Biology International (2024) Vol. 48, Iss. 10, pp. 1406-1449
Closed Access | Times Cited: 3
Exosome-based nanoparticles and cancer immunotherapy
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 3
A thermo-responsive chemically crosslinked long-term-release chitosan hydrogel system increases the efficiency of synergy chemo-immunotherapy in treating brain tumors
Shun-Hao Chuang, Kuan‐Ju Chen, Yu-Ting Cheng, et al.
International Journal of Biological Macromolecules (2024) Vol. 280, pp. 135894-135894
Closed Access | Times Cited: 3
Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
Dhanashree Murugan, Vasanth Murugesan, Balaji Panchapakesan, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5438-5438
Open Access | Times Cited: 18
Tumour-associated macrophages: versatile players in the tumour microenvironment
Zoey Zeyuan Ji, Max Kam‐Kwan Chan, Alex Siu Wing Chan, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 10
Progress of research on PD-1/PD-L1 in leukemia
Huizhen Cao, Tianyu Wu, Xue Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 9
Emerging Targets in Clear Cell Renal Cell Carcinoma
Yu‐Wei Chen, Brian I. Rini, Kathryn E. Beckermann
Cancers (2022) Vol. 14, Iss. 19, pp. 4843-4843
Open Access | Times Cited: 16
Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
Chuandong Hou, Zining Wang, Xuechun Lu
Cancer Pathogenesis and Therapy (2023) Vol. 2, Iss. 1, pp. 24-30
Open Access | Times Cited: 9
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
Sofía Bruni, María F. Mercogliano, Florencia Mauro, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions
Ling Yang, Zhuang Li, Zhaoyang Ye, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107881-107881
Open Access | Times Cited: 8
Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview
Priyatharcini Kejamurthy, K. T. Ramya Devi
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 8
Advances in the study of antisense long‑stranded non‑coding RNAs in tumors (Review)
Yifan Shao, Yuwei Dong, Jing Zhou, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 3
Closed Access | Times Cited: 2

Scroll to top